Significance of understanding the genomics of host-pathogen interaction in limiting antibiotic resistance development: lessons from COVID-19 pandemic

Brief Funct Genomics. 2024 Jan 18;23(1):69-74. doi: 10.1093/bfgp/elad001.

Abstract

The entire world is facing the stiff challenge of COVID-19 pandemic. To overcome the spread of this highly infectious disease, several short-sighted strategies were adopted such as the use of broad-spectrum antibiotics and antifungals. However, the misuse and/or overuse of antibiotics have accentuated the emergence of the next pandemic: antimicrobial resistance (AMR). It is believed that pathogens while transferring between humans and the environment carry virulence and antibiotic-resistant factors from varied species. It is presumed that all such genetic factors are quantifiable and predictable, a better understanding of which could be a limiting step for the progression of AMR. Herein, we have reviewed how genomics-based understanding of host-pathogen interactions during COVID-19 could reduce the non-judicial use of antibiotics and prevent the eruption of an AMR-based pandemic in future.

Keywords: COVID-19; antibiotics; genomics; host-pathogen interactions; pandemics.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • COVID-19*
  • Drug Resistance, Bacterial
  • Drug Resistance, Microbial / genetics
  • Genomics
  • Host-Pathogen Interactions / genetics
  • Humans
  • Pandemics

Substances

  • Anti-Bacterial Agents